Chattanooga, TN, United States of America

Ray Tabibiazar

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ray Tabibiazar: Innovator in Biotech

Introduction

Ray Tabibiazar is a prominent inventor based in Chattanooga, TN (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody libraries. With a total of three patents to his name, Tabibiazar is recognized for his work that enhances our understanding of receptor interactions.

Latest Patents

Tabibiazar's latest patents include groundbreaking methods and compositions related to glucagon-like peptide-1 receptor (GLP1R) libraries. These libraries consist of nucleic acids encoding a scaffold that includes a GLP1R binding domain. The patents describe variegated libraries that contain nucleic acids, each encoding a predetermined variant of a reference nucleic acid sequence. Additionally, he has developed variant nucleic acid libraries for CRTH2, which relate to prostaglandin D2 receptor 2 (DP2 or CRTH2R) libraries. These libraries also encode immunoglobulins, including antibodies and single domain antibodies.

Career Highlights

Ray Tabibiazar is currently associated with Twist Bioscience Corporation, where he continues to push the boundaries of biotechnology. His work has been instrumental in advancing the field and has garnered attention for its innovative approach to receptor binding and antibody development.

Collaborations

Some of his notable coworkers include Aaron Sato and Pankaj Garg, who have collaborated with him on various projects within the company.

Conclusion

Ray Tabibiazar's contributions to biotechnology through his patents and innovative research have positioned him as a key figure in the industry. His work continues to influence the development of new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…